提供学术论文选刊润色服务

医学

返回期刊列表

Review Cycle Records

Expert Opinion on Drug Discovery

Taylor & Francis SCIE 非OA

2026新锐 2区2025中科院 2区2025 JCR Q1

查看审稿周期计算与数据来源报告数据问题

64.5平均天数

62中位天数

18最短天数

110最长天数

1102025发文量

Paper Review Records

全部论文审稿周期

13 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接

78 天

Why next-generation mechanistic models will transform drug discovery: integrating efficacy and safety

收稿 2026-04-14 录用 2026-07-01 发表 2026-07-08

作者Gustavo Santos Sandes Felizardo; Vinícius Alexandre Fiaia Costa; Eder Soares de Almeida Santos; Luiz Carlos da Cunha; Bruno Junior Neves

作者单位1. Universidade Federal de Goiás

PDF源文件 DOI 网页

84 天

Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology

收稿 2026-03-26 录用 2026-06-18 发表 2026-07-06

作者Christopher D. Verrico; Lynnette A. Averill; Cameron J. Moore; Amy L. McGuire; Thomas R. Kosten; Ramiro Salas

作者单位1. Baylor College of Medicine; 2. The Menninger Clinic; 3. Michael E. DeBakey VA Medical Center

PDF源文件 DOI 网页

52 天

From mitochondrial signal to discovery decision: a reserve–demand framework for translational risk assessment

收稿 2026-05-08 录用 2026-06-29 发表 2026-07-03

作者George W. Rogers; Yvonne Will

作者单位1. Baseline Bio Advisory, LLC; 2. Scientia Consultants, LLC

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求，转成可验证的期刊方案

说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。

客户询问

我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？

CrushSCI回复

可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议: 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
数据库初筛: Environmental Technology & Innovation

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Expert Opinion on Drug Discovery

全部论文审稿周期

Why next-generation mechanistic models will transform drug discovery: integrating efficacy and safety

Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology

From mitochondrial signal to discovery decision: a reserve–demand framework for translational risk assessment

把投稿要求，转成可验证的期刊方案

联系 CrushSCI

扫码添加微信好友

正在维护

Expert Opinion on Drug Discovery

全部论文审稿周期

Why next-generation mechanistic models will transform drug discovery: integrating efficacy and safety

Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology

From mitochondrial signal to discovery decision: a reserve–demand framework for translational risk assessment

相关榜单与期刊入口